Literature DB >> 8710908

Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).

K Joseph1, B Ghebrehiwet, E I Peerschke, K B Reid, A P Kaplan.   

Abstract

High molecular weight kininogen (HK) and factor XII are known to bind to human umbilical vein endothelial cells (HUVEC) in a zinc-dependent and saturable manner indicating that HUVEC express specific binding site(s) for those proteins. However, identification and immunochemical characterization of the putative receptor site(s) has not been previously accomplished. In this report, we have identified a cell surface glycoprotein that is a likely candidate for the HK binding site on HUVECs. When solubilized HUVEC membranes were subjected to an HK-affinity column in the presence or absence of 50 microM ZnCl2 and the bound membrane proteins eluted, a single major protein peak was obtained only in the presence of zinc. SDS/PAGE analysis and silver staining of the protein peak revealed this protein to be 33 kDa and partial sequence analysis matched the NH2 terminus of gC1q-R, a membrane glycoprotein that binds to the globular "heads" of C1q. Two other minor proteins of approximately 70 kDa and 45 kDa were also obtained. Upon analysis by Western blotting, the 33-kDa band was found to react with several monoclonal antibodies (mAbs) recognizing different epitopes on gC1q-R. Ligand and dot blot analyses revealed zinc-dependent binding of biotinylated HK as well as biotinylated factor XII to the isolated 33-kDa HUVEC molecule as well as recombinant gC1q-R. In addition, binding of 125I-HK to HUVEC cells was inhibited by selected monoclonal anti-gC1q-R antibodies. C1q, however, did not inhibit 125I-HK binding to HUVEC nor did those monoclonals known to inhibit C1q binding to gC1q-R. Taken together, the data suggest that HK (and factor XII) bind to HUVECs via a 33-kDa cell surface glycoprotein that appears to be identical to gC1q-R but interact with a site on gC1q-R distinct from that which binds C1q.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710908      PMCID: PMC38710          DOI: 10.1073/pnas.93.16.8552

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Identification of a novel 33-kDa C1q-binding site on human blood platelets.

Authors:  E I Peerschke; K B Reid; B Ghebrehiwet
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

Review 2.  Functions associated with the C1q receptor.

Authors:  B Ghebrehiwet
Journal:  Behring Inst Mitt       Date:  1989-07

3.  High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.

Authors:  R N Puri; F Zhou; C J Hu; R F Colman; R W Colman
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

4.  Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.

Authors:  M Berrettini; R R Schleef; M J Heeb; P Hopmeier; J H Griffin
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

5.  Assembly of contact-phase factors on the surface of the human neutrophil membrane.

Authors:  L M Henderson; C D Figueroa; W Müller-Esterl; K D Bhoola
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

6.  Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.

Authors:  K Nishikawa; Y Shibayama; P Kuna; E Calcaterra; A P Kaplan; S R Reddigari
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

7.  Isolation of a human endothelial cell C1q receptor (C1qR).

Authors:  E I Peerschke; R Malhotra; B Ghebrehiwet; K B Reid; A C Willis; R B Sim
Journal:  J Leukoc Biol       Date:  1993-02       Impact factor: 4.962

8.  Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains.

Authors:  S R Reddigari; P Kuna; G Miragliotta; Y Shibayama; K Nishikawa; A P Kaplan
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

9.  Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.

Authors:  S R Reddigari; Y Shibayama; T Brunnée; A P Kaplan
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

10.  Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q.

Authors:  B Ghebrehiwet; B L Lim; E I Peerschke; A C Willis; K B Reid
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  48 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 2.  The plasma kallikrein-kinin system counterbalances the renin-angiotensin system.

Authors:  Alvin H Schmaier
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

3.  The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.

Authors:  Jing-Chuan Zhang; Fernando Donate; Xiaoping Qi; Nicholas P Ziats; Jose C Juarez; Andrew P Mazar; Yuan-Ping Pang; Keith R McCrae
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-26       Impact factor: 11.205

4.  Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.

Authors:  Roberta Bulla; Chiara Agostinis; Fleur Bossi; Lucia Rizzi; Alessandra Debeus; Claudio Tripodo; Oriano Radillo; Francesco De Seta; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

Review 5.  Mechanisms of MAVS regulation at the mitochondrial membrane.

Authors:  Jana L Jacobs; Carolyn B Coyne
Journal:  J Mol Biol       Date:  2013-10-09       Impact factor: 5.469

6.  Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species.

Authors:  Danyu Sun; Keith R McCrae
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 7.  Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

8.  C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms.

Authors:  L E Leigh; B Ghebrehiwet; T P Perera; I N Bird; P Strong; U Kishore; K B Reid; P Eggleton
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

9.  Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta.

Authors:  Mohammad M Khan; Yuchuan Liu; Munir E Khan; Megan L Gilman; Sabina T Khan; Michael Bromberg; Robert W Colman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-04       Impact factor: 4.733

10.  Structure of the Trypanosoma brucei p22 protein, a cytochrome oxidase subunit II-specific RNA-editing accessory factor.

Authors:  Mareen Sprehe; John C Fisk; Sarah M McEvoy; Laurie K Read; Maria A Schumacher
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.